Pathologic complete response in triple negative breast cancer - A single Portuguese center experience

A. Pina; Pedhro Lennon Cezário Freitas; C. Cardoso; E. Gouveia; F. Vaz; I. Miguel; Márcia Guena dos Santos; M.B. Mira; M.T. Alexandre; A. Moreira; Marco Antônio Oliveira Brito; H. Nunes

doi:10.1016/s0959-8049(22)01526-x

JOURNAL ARTICLE

Pathologic complete response in triple negative breast cancer - A single Portuguese center experience

A. Pina Pedhro Lennon Cezário Freitas C. Cardoso E. Gouveia F. Vaz I. Miguel Márcia Guena dos Santos M.B. Mira M.T. Alexandre A. Moreira Marco Antônio Oliveira Brito H. Nunes

Year: 2022 Journal: European Journal of Cancer Vol: 175 Pages: S66-S66 Publisher: Elsevier BV

DOI: 10.1016/s0959-8049(22)01526-x

Get Full-Text PDF Get Analytical Report

Keywords:

Medicine Triple-negative breast cancer Anthracycline Taxane Breast cancer Oncology Internal medicine Complete response Cancer Chemotherapy Single Center Stage (stratigraphy) Overall survival

Metrics

Cited By

0.00

FWCI (Field Weighted Citation Impact)

Refs

0.16

Citation Normalized Percentile

Is in top 1%

Is in top 10%

Topics

Breast Cancer Treatment Studies

Life Sciences → Biochemistry, Genetics and Molecular Biology → Cancer Research

Cancer Treatment and Pharmacology

Health Sciences → Medicine → Oncology

Cancer Genomics and Diagnostics

Life Sciences → Biochemistry, Genetics and Molecular Biology → Cancer Research

Pathologic complete response in triple negative breast cancer - A single Portuguese center experience

Metrics

Topics

Related Documents

Predicting pathologic complete response in triple negative breast cancer

Triple-Negative Breast Cancer Clinicopathology: A Single-Center Experience

When chemotherapy wins: pathologic complete response in early triple negative breast cancer

Pathological complete response to neoadjuvant chemotherapy in triple negative breast cancer – single hospital experience

Stromal grading predicts pathologic complete response and prognosis in triple-negative breast cancer